Texas declares war on Tylenol maker Johnson and Johnson and its spinoff Kenvue through high-stakes lawsuit – NaturalNews.com

• Texas has filed a major lawsuit against Johnson & Johnson and its spinoff Kenvue, accusing them of concealing alleged links between prenatal Tylenol use and neurodevelopmental disorders like autism and ADHD in children.
• The state alleges a decades-long deception, claiming the companies knew of potential risks but marketed Tylenol as safe for pregnant women without warning the public.
• The lawsuit escalates a national debate, aligning with political warnings from figures like President Trump but conflicting with established medical guidance that still considers acetaminophen the safest over-the-counter option during pregnancy.
• The scientific evidence is contested, with some studies showing a correlation (but not causation) between the drug and disorders, while other major studies have found no causal link.
• This is part of a broader legal battle that includes hundreds of private lawsuits against both the manufacturers and major retailers, with the outcome potentially reshaping how the drug is marketed and labeled.

The state of Texas has declared war against Johnson & Johnson – the manufacturer of the Tylenol painkiller – and its consumer spinoff Kenvue, through a high-stakes lawsuit.

Attorney General Ken Paxton accused the corporate behemoths in the lawsuit of a decades-long campaign of deception by concealing alleged links between prenatal Tylenol use and neurodevelopmental disorders like autism and ADHD in children. It marks the most significant state-level action to date in the escalating legal and political battle over the safety of acetaminophen, the active ingredient in Tylenol and countless other over-the-counter remedies.

Filed under the Texas Deceptive Trade Practices Act, the lawsuit contends that J&J possessed internal knowledge for years of scientific studies questioning the safety of acetaminophen for pregnant women. The Lone Star State alleges that instead of warning the public, the companies engaged in deceptive marketing, actively promoting Tylenol as a safe choice for expectant mothers while downplaying or concealing potential risks.

The complaint goes a step further, suggesting that J&J’s 2023 spinoff of Kenvue was a strategic maneuver to shield its corporate assets from the very liability now pursued by Texas. It seeks substantial civil penalties and restitution for consumers, framing the case as a matter of corporate accountability versus family safety.

The Texas lawsuit does not exist in a vacuum, arriving amid a heated national debate fueled by commentary from the highest levels of government. President Donald Trump and Health Secretary Robert F. Kennedy Jr. have publicly warned pregnant women against using Tylenol, with the President stating no mother should take the drug while carrying a child. This political backdrop provides a powerful context for Paxton’s legal offensive, aligning state action with a federal administration keen on pursuing pharmaceutical accountability.

However, this political stance places the state in direct conflict with the established medical community and federal courts. Major medical bodies, including the American College of Obstetricians and Gynecologists, continue to endorse acetaminophen as the safest over-the-counter pain and fever reliever for pregnant women. They caution that untreated fever and severe pain can themselves pose significant dangers to both the mother and the developing fetus, creating a complex risk-benefit calculation for patients and doctors.

Texas’ Tylenol lawsuit: A legal pain for J&J

The scientific evidence at the heart of the case is fiercely contested. Some observational studies have noted a statistical association between prenatal acetaminophen exposure and a slightly increased risk of neurodevelopmental disorders. These studies, often cited by litigants, suggest a correlation but explicitly stop short of proving causation.

Conversely, other major studies, including one funded by the National Institutes of Health and published in the prestigious Journal of the American Medical Association, found no causal link between acetaminophen use during pregnancy and an increased risk of autism or ADHD. This scientific disagreement proved decisive in federal court earlier this year, where a judge dismissed a large cluster of similar private lawsuits, ruling that the plaintiffs’ expert testimony linking the drug to the disorders was not sufficiently grounded in accepted science.

“Tylenol is the brand name for acetaminophen, a widely used over-the-counter pain reliever,” said BrightU.AI‘s Enoch. “It is also a component in prescription drugs like Tylenol-3, which combines it with codeine. Some natural health advocates have raised concerns about its use.”

Texas is now at the forefront of a legal war being waged on multiple fronts. While the federal multidistrict litigation has stalled, hundreds of private lawsuits from families remain active, with an appeals court hearing set for November.

Furthermore, retailers like Walmart, CVS and Walgreens face their own separate lawsuits for allegedly falsely advertising store-brand acetaminophen products as safe for pregnancy without adequate warnings. A special master has been appointed to oversee this sprawling federal litigation, indicating the judicial system is bracing for a long and complex legal fight.

The Texas lawsuit against J&J and Kenvue is more than a single legal filing. It is a political statement and a direct challenge to both a corporate giant and the established medical consensus.

Watch this clip about a pregant liberal who ended up in the ICU after taking too much Tylenol, in protest of President Trump’s remarks about the painkiller causing autism.

This video is from the Children Are NOT Sex Toys! channel on Brighteon.com.

Sources include: 

YourNews.com

ABCNews.go.com

Reuters.com

BrightU.ai

Brighteon.com